INDAPTUS THERAPEUTICS INC
(NASDAQ: INDP)
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
2.490
+0.050
(+2.05%)
Range
2.470 - 2.680
(8.50%)
Open
2.680
Previous Close
2.440
Bid Price
1.960
Bid Volume
9
Ask Price
2.060
Ask Volume
14
Volume
7,360
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis